T1	Participants 86 164	stable patients with moderate-to-severe chronic obstructive pulmonary disease.
T2	Participants 256 300	chronic obstructive pulmonary disease (COPD)
T3	Participants 599 651	114 patients with COPD of moderate-to-severe degree.
T4	Participants 2078 2111	moderate-to-severe COPD patients.
